General Information of the Compound
| Compound ID |
CP0413125
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-(6-oxo-1H-pyridazin-3-yl)-N-(5,6,7,8-tetrahydronaphthalen-1-yl)thiophene-2-sulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H17N3O3S2
|
||||||||||||||||||
| Molecular Weight |
387.486
|
||||||||||||||||||
| Canonical SMILES |
O=c1ccc(n[nH]1)-c1ccc(s1)S(=O)(=O)Nc1cccc2CCCCc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H17N3O3S2/c22-17-10-8-15(19-20-17)16-9-11-18(25-16)26(23,24)21-14-7-3-5-12-4-1-2-6-13(12)14/h3,5,7-11,21H,1-2,4,6H2,(H,20,22)
Show/Hide
|
||||||||||||||||||
| InChIKey |
KFYFVBNCJNHWJD-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7